Lessons from the RE-ALIGN trial.
Cardiology Department, Bichat Hospital, AP-HP, Paris Diderot University, 46, rue Henri-Huchard, 75018 Paris, France. Electronic address: bernard.iung@bch.aphp.fr.
Bernard
B
Iung
Cardiology Department, Bichat Hospital, AP-HP, Paris Diderot University, 46, rue Henri-Huchard, 75018 Paris, France.
Alec
A
Vahanian
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D001705:Bioprosthesis; D017322:Clinical Trials, Phase II as Topic; D000069604:Dabigatran; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D011183:Postoperative Complications / Q000139:chemically induced / Q000517:prevention & control*; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D020521:Stroke / Q000209:etiology; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran
Anticoagulant therapy; Mechanical prosthesis; Prothèses mécaniques; Traitement anticoagulant; Valvular disease; Valvulopathies